BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Proposed Public Offering
BioSig intends to offer shares of common stock to raise capital for various purposes.
Book-Running Managers
Clear Street and Needham & Company are facilitating the underwritten public offering.
Use of Proceeds
The net proceeds will be used for buying gold bullion, working capital, and general corporate purposes.
- BioSig's decision to offer shares through a public offering indicates its strategic move to raise capital for future investments and operations.
- The involvement of reputable book-running managers like Clear Street and Needham & Company adds credibility to the offering process.
BioSig's announcement of the proposed public offering reflects the company's proactive approach to fundraising and strategic financial planning.